Review: senescence and regulated cell death in cancer
This abstract describes a review of how cellular senescence and regulated cell death interact in tumor cells, naming p53, mitochondria, autophagy machinery and epigenetic regulators as hubs, and pointing to therapeutic strategies targeting these processes. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract states that cellular senescence can suppress tumor growth via stable cell-cycle arrest and immune clearance, while persistent senescent cells may drive progression through the SASP. [1]
The abstract names apoptosis, ferroptosis, cuproptosis, necroptosis, pyroptosis, parthanatos and autophagy-dependent cell death as modalities of regulated cell death that are critical determinants of therapeutic response. [1]
The abstract says the crosstalk is orchestrated by hubs including p53, mitochondria, autophagy machinery and epigenetic regulators, and that the review highlights emerging therapeutic strategies targeting these interconnected processes. [1]
The source at a glance
- Study type / format
- Review abstract
- Population / context
- Tumor cells and cancer, as discussed in a review abstract
- Summary based on
- Study abstract
- Original publication
- September 29, 2026
Senescence in tumors: arrest versus secretion
The abstract states that cellular senescence can suppress tumor growth by inducing stable cell-cycle arrest and promoting immune clearance. It also states that persistent senescent cells may drive tumor progression through the senescence-associated secretory phenotype (SASP). Both directions are described as possibilities, not as established causes.
Supporting source [1]
Cell death forms named as response determinants
According to the abstract, several modalities of regulated cell death are critical determinants of therapeutic response: apoptosis, ferroptosis, cuproptosis, necroptosis, pyroptosis, parthanatos and autophagy-dependent cell death. The abstract does not report which treatments act through which modality or how large any effect is.
Supporting source [1]
Cross-talk hubs and therapeutic aims in the review
The abstract says the crosstalk between senescence and cell death is orchestrated by key molecular hubs including p53, mitochondria, autophagy machinery and epigenetic regulators. The review is said to summarize hallmarks and classification of senescence in cancer, outline major cell death modalities, discuss cross-regulatory networks and highlight emerging therapeutic strategies for cancer treatment. These are described as strategies being highlighted, not as validated treatments.
Supporting source [1]
How to interpret this
Only the abstract was reviewed; the full text was not reviewed. The abstract reports no study design, sample, follow-up, effect sizes or statistical uncertainty, and it describes mechanisms and proposed therapeutic strategies rather than tested clinical benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Du L, Zhang Y, Liang R, Song B, Zhou J, Xia X, Liu C, Wu K, Cao X. · europepmc.org · September 29, 2026